Loading clinical trials...
Loading clinical trials...
A Phase II Trial Of Celecoxib (Celebrex) And Capecitabine (Xeloda) Combined With Pelvic Irradiation As Neoadjuvant Treatment Of Stage II or III Adenocarcinoma Of The Rectum
Conditions
Interventions
capecitabine
celecoxib
+2 more
Start Date
December 1, 2004
Primary Completion Date
February 1, 2006
Completion Date
November 1, 2010
Last Updated
December 15, 2016
NCT06696768
NCT04704661
NCT05489211
NCT04657068
NCT06625775
NCT06445062
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions